Ratings for Vertex (NASDAQ: VERX) were provided by 7 analysts in the past three months, showcasing a mix of bullish and ...

The Series D funding round was led by 360 ONE Asset and Vertex Growth, with participation from existing backers Vertex Ventures Southeast Asia and India and 3one4 Capital.

Vertex's revenue was $2.96 billion in the second quarter of 2025, beating the consensus forecast by $58 million. Click here ...

Vertex Pharmaceuticals has a lot of buy and hold ratings, but there aren't any sell ratings from Wall Street analysts. Around 75,000 people with cystic fibrosis rely on Vertex Pharmaceuticals to keep ...

The cystic fibrosis (CF) market in the seven major markets (7MM) is forecast to grow from $11.1 billion in 2024 to $16 billion in 2034, growing at a modest compound annual growth rate (CAGR) of 3.8%, ...

Disappointing trial results for VX-993 led to a sell-off of Vertex's stock recently. The company's financials remain strong, and sales were up 12% last quarter. Vertex has been broadening its pipeline ...

In a move reminiscent of Facebook’s early days, TikTok is launching a new feature that allows college students to find and connect with others on their campus. The feature, called Campus Verification, ...

Meta recently released a new video editing app for creators called Edits. The new app is designed to rival ByteDance’s CapCut, a popular short-form video-editing app used by many creators. Meta first ...

Abstract: A novel integration scheme is proposed for the accurate numerical evaluation of test (reaction) integrals needed for solving complex direct or inverse electromagnetic problems using surface ...